Gotistobart Response Rate Bests Chemo in Pretreated NSCLC



Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/gotistobart-response-rate-bests-chemo-pretreated-nsclc-2026a1000acm?src=rss

Author :

Publish date : 2026-04-06 08:28:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version